⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

July 15, 2024Frontiers in Cellular and Infection MicrobiologyOpen Access

Long-term stability of acquired drug resistance and resistance associated mutations in the fungal pathogen Nakaseomyces glabratus (Candida glabrata)

Ewa Księżopolska Miquel Àngel Schikora-Tamarit Juan Carlos Nunez‐Rodriguez Toni Gabaldón

View Full Paper

Ask AI

Bookmark

Share

Abstract

The limited number of available antifungal drugs and the increasing number of fungal isolates that show drug or multidrug resistance pose a serious medical threat. Several yeast pathogens, such as

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Księżopolska et al. (2024) studied this question.

synapsesocial.com/papers/68e60368b6db64358759705d https://doi.org/10.3389/fcimb.2024.1416509

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Ergosterol-depleted clinical isolates of <i>Nakaseomyces glabratus</i> can develop multi-drug resistance without severe fitness defects or attenuated virulence in an invertebrate infection modelOriginal Research · 2026
2Genomic description of the first multidrug-resistant <i>Nakaseomyces glabratus</i> ( <i>Candida glabrata</i> ) strain detected in Costa RicaOriginal Research · 2026
3Phylogenomic analysis and genetic mechanisms of antifungal resistance in clinical isolates of <i>Candida glabrata</i> ( <i>Nakaseomyces glabratus</i> ) from across Canada, 2013–20202025 · 3 citations
4Phylogenomic analysis and genetic mechanisms of antifungal resistance in clinical isolates of <i>Candida glabrata</i> ( <i>Nakaseomyces glabratus</i> ) from across Canada, 2013–20202025
5Genome analysis and machine learning-based feature selection strategy reveal potential drug-resistance determinants in <i>Nakaseomyces glabratus</i>2025